PAX Financial Group’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,963
| Closed | -$381K | – | 230 |
|
|
2024
Q3 | $381K | Buy |
1,963
+107
| +6% | +$20.7K | 0.07% | 190 |
|
|
2024
Q2 | $430K | Sell |
1,856
-97
| -5% | -$22.5K | 0.08% | 181 |
|
|
2024
Q1 | $421K | Buy |
1,953
+156
| +9% | +$33.6K | 0.08% | 184 |
|
|
2023
Q4 | $432K | Buy |
1,797
+220
| +14% | +$52.9K | 0.09% | 178 |
|
|
2023
Q3 | $405K | Buy |
1,577
+45
| +3% | +$11.6K | 0.09% | 172 |
|
|
2023
Q2 | $436K | Sell |
1,532
-61
| -4% | -$17.4K | 0.1% | 171 |
|
|
2023
Q1 | $443K | Sell |
1,593
-41
| -3% | -$11.4K | 0.11% | 160 |
|
|
2022
Q4 | $452K | Sell |
1,634
-1,035
| -39% | -$287K | 0.11% | 142 |
|
|
2022
Q3 | $713K | Sell |
2,669
-44
| -2% | -$11.8K | 0.18% | 90 |
|
|
2022
Q2 | $553K | Sell |
2,713
-723
| -21% | -$147K | 0.14% | 126 |
|
|
2022
Q1 | $724K | Buy |
3,436
+286
| +9% | +$60.3K | 0.17% | 107 |
|
|
2021
Q4 | $756K | Buy |
3,150
+424
| +16% | +$102K | 0.17% | 108 |
|
|
2021
Q3 | $771K | Sell |
2,726
-7
| -0.3% | -$1.98K | 0.19% | 89 |
|
|
2021
Q2 | $946K | Buy |
2,733
+67
| +3% | +$23.2K | 0.24% | 55 |
|
|
2021
Q1 | $746K | Buy |
2,666
+499
| +23% | +$140K | 0.21% | 71 |
|
|
2020
Q4 | $531K | Buy |
2,167
+347
| +19% | +$85K | 0.17% | 85 |
|
|
2020
Q3 | $516K | Buy |
1,820
+352
| +24% | +$99.8K | 0.18% | 77 |
|
|
2020
Q2 | $393K | Buy |
1,468
+246
| +20% | +$65.9K | 0.15% | 93 |
|
|
2020
Q1 | $364K | Buy |
1,222
+304
| +33% | +$90.6K | 0.16% | 91 |
|
|
2019
Q4 | $309K | Buy |
+918
| New | +$309K | 0.13% | 90 |
|